Atlas Trials

Study of FCN-011 in Patients With Advanced Solid Tumor(Phase I)and NTRK Fusion Positive Advanced Solid Tumor (Phase II)

Clinical trial NCT04687423 · UNKNOWN

Trial details

NCT number
NCT04687423
Sponsor
Fochon Pharmaceuticals, Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumor
Start date
2021-04-13
Primary completion
2023-10-31
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.